All News

A decade ago, I was diagnosed with acute myeloid leukemia and underwent aggressive chemotherapy and an allogenic stem cell transplant. Though I still have complications related to my cancer, I’m thankful for what I still have.

Depression reduces the likelihood of receiving recommend treatment, which can affect survival, according to a Kentucky-based study of patients with breast cancer.

Slowing down due to cancer and COVID-19 made me realize the parts of life I’ve been missing, though my new pace isn’t all bad.

In honor of mental health awareness month, we’re highlighting four blogs from cancer survivors about their emotional struggles and the methods they use to cope.

Not only does Amanda Kelm, B.S.N., RN, OCN, build a rapport with the patient and family, but she also assesses the patient and determines their proper mode of transportation.

The night before my mastectomy, I had a dream about my grandmother who died of breast cancer, which gave me hope throughout the frightening process.

The recent FDA approval of Padcev plus Keytruda for locally advanced/metastatic, chemotherapy-ineligible bladder cancer offers an “exciting opportunity” for this difficult-to-treat patient population, an expert said.

I'm thankful that I spoke up about my bone pain related to cancer metastases.

The phase 3 HARMONi trial recently kicked off, studying ivonescimab plus chemotherapy for EGFR-mutant non-small cell lung cancer.

A clinical trial studying an accelerated dose of Besremi recently kicked off.

The benefit derived from Tyvyt plus chemotherapy was present regardless of whether previously treated patients with EGFR-mutated, non-squamous non-small cell lung cancer also received Byvasda.

My husband is "that guy" who always takes care of everyone else, so his recent cancer scare was unfathomable.

A small survey of women with head and neck cancer found that while many experience physical and emotional distress, social supports can help.

Patients with advanced or recurrent endometrial cancer derived a survival benefit from Jemperli plus chemotherapy.

I’m not usually the emotional type, but the first time I tried on a wig after losing my hair from chemotherapy, I wept.

As more personalized treatments become available in the ovarian cancer space, tumor testing, such as next-generation sequencing, may play a bigger role.

I’ve learned that knowledge is the key to fighting cancer. Here are three ways I learn more about my disease.

Men with low-risk prostate cancer can usually safely forego treatment as long as they continue to monitor their disease with their clinicians, an expert said.

Patients with advanced or recurrent endometrial cancer treated with Keytruda plus chemotherapy had improved progression-free survival compared with chemotherapy alone.

One scientific development can lead to many more for patients with myeloproliferative neoplasms, a type of rare blood cancer, according to an expert.

As cliche as it may sound, Kelly Bryant, RN, is the first nurse to arrive and the last nurse to leave each and every day she works.

I was told that I have survivors' guilt after seeing a friend while she was actively dying from cancer, but I actually see that day as a gift.

Deborah Lorick, M.S.N., M.H.A., RN, RNOCN, was the assistant nurse manager on the oncology unit where my husband was a patient. Deborah was always making sure that my husband, my children and I were well cared for.

After a patient is diagnosed with a rare disease such as a myeloproliferative neoplasm, learning about their condition and seeking expert clinicians can help put their mind at ease.

Children and young adults often take on more responsibility when their parent is diagnosed with cancer. A recent study surveyed these young carers about their experience.

After undergoing an oophorectomy, I experienced some debilitating symptoms, but acupuncture and other holistic practices helped.

From actress and journalist Maria Menounos opening up about her pancreatic diagnosis to the Pennsylvania governor signing a bill for free screenings, here’s what’s happening in the oncology space this week.

A clinical trial is underway for STX-478, a potential new treatment for breast cancer and other tumors, with initial results expected later this year.